Porphose

Manufacturer: Porphose
Effective date: 2025-03-27
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 00:58:02

Label at a glance#

ProductPorphose

Active ingredientOATMEAL

Label structure10 sections

Indications and uses

Temporarily protects and helps relieve minor skin irritations and itching due to eczema, rashes, poison ivy, poison oak, poison sumac, and insect bites.

Dosage and administration

Shake well before use. Apply as needed to affected areas.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Colloidal Oatmeal 0.15%

Purpose of Active Ingredient

OTC - PURPOSE SECTION

Purpose: Skin Protectan

Uses

INDICATIONS & USAGE SECTION

Temporarily protects and helps relieve minor skin irritations and itching due to eczema, rashes, poison ivy, poison oak, poison sumac, and insect bites.

Warnings

WARNINGS SECTION

For external use only. Do not use on deep wounds, animal bites, or serious burns. When using this product do not get into eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if condition worsens, symptoms persist, or new irritation occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Shake well before use. Apply as needed to affected areas.

Other Information

OTHER SAFETY INFORMATION

Store at room temperature.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Porphyridium Conditioned Media, Phenoxyethanol.

Questions?

OTC - QUESTIONS SECTION

Call 760483-3626 or visit Porphose.com

Porphose Eczema Relief Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PorphoseEczemaRelief_Carton.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
2709427	colloidal oatmeal 0.15 % Topical Spray	PSN	1
2709427	colloidal oatmeal 1.5 MG/ML Topical Spray	SCD	1
2709427	colloidal oatmeal 0.15 % Topical Spray	SY	1

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
OATMEAL Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20181113

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
85456-001-01	Porphose	30 g in 1 CARTON	SPRAY	30		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
85456-001	PORPHOSE (COLLOIDAL OATMEAL TOPICAL SPRAY) SPRAY [PORPHOSE]	1	Current NDC, 1 package rows	20250330_315951e0-899f-c968-e063-6294a90abe61.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

Porphose
Colloidal Oatmeal Topical Spray
OATMEAL
PHENOXYETHANOL
PORPHYRIDIUM PURPUREUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
85456-001	85456-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OATMEAL	8PI54V663Y	ACTIB
PHENOXYETHANOL	HIE492ZZ3T	IACT
PORPHYRIDIUM PURPUREUM	K2P8K2558N	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Porphose	COLLOIDAL OATMEAL TOPICAL SPRAY	Porphose	315951e0-899f-c968-e063-6294a90abe61	2025-03-27	Warnings	Exact identifier ndc (package): 85456-001-01 ndc (product): 85456-001 ndc11 (package): 85456000101 spl id: 315951e0-89a0-c968-e063-6294a90abe61 spl set id: 315951e0-899f-c968-e063-6294a90abe61

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.